{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:28:25Z","timestamp":1781890105583,"version":"3.54.5"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>We report a case of a 4-month-old infant with severe genital malformation and a 46, XY karyotype. Genetic testing revealed a variant in the NR5A1 gene, guiding a successful multistage surgical intervention. This case underscores the value of targeted genetic testing in guiding the management of severe hypospadias cases. While genetic investigation isn't routine for all severe hypospadias cases, Next Generation Sequencing (NGS) technologies have influenced the rate of correct diagnoses, reduced diagnostic delay, and helped to determine the need for focused medical care and timely treatment. Too commonly, surgeons tend to attach importance to malformation repair and disregard the genetic diagnoses, but we believe that precise genetic diagnosis improves the accuracy of DSD management in terms of prognostic predictions, the development of an individualized management plan and the determination of treatment options.<\/jats:p>","DOI":"10.3389\/fsurg.2025.1524953","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:40:06Z","timestamp":1738305606000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report - Severe hypospadias in 46, XY karyotype patients: is third level genetic testing always mandatory?"],"prefix":"10.3389","volume":"12","author":[{"given":"Giorgia","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Spagnol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Mucciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"Adorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Silveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"B1","volume-title":"EAU Guidelines. Edn. Presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.mce.2010.11.006","article-title":"Steroidogenic factor-1 (SF-1, NR5A1) and human disease","volume":"336","author":"Ferraz-de-Souza","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.beem.2015.07.004","article-title":"DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease","volume":"29","author":"Suntharalingham","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"885589","DOI":"10.3389\/fgene.2022.885589","article-title":"Case report: severe gonadal dysgenesis causing 46,XY disorder of sex development due to a novel NR5A1 variant","volume":"13","author":"Alhamoudi","year":"2022","journal-title":"Front Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e36725","DOI":"10.1097\/MD.0000000000036725","article-title":"NR5A1-related 46,XY partial gonadal dysgenesis: a case report and literature review","volume":"102","author":"Wei","year":"2023","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12887-023-03974-7","article-title":"A novel c.64G > T (p.G22C) NR5A1 variant in a Chinese adolescent with 46,XY disorders of sex development: a case report","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jpurol.2013.04.006","article-title":"The GMS hypospadias score: assessment of inter-observer reliability and correlation with post-operative complications","volume":"9","author":"Merriman","year":"2013","journal-title":"J Pediatr Urol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S1477513124005473","DOI":"10.1016\/j.jpurol.2024.10.023","article-title":"2-stage STAG vs 3-stage STAC for primary proximal hypospadias repair","author":"Snodgrass","year":"2024","journal-title":"J Pediatr Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/cge.13432","article-title":"Molecular genetics of hypospadias and cryptorchidism recent developments","volume":"95","author":"Kalfa","year":"2019","journal-title":"Clin Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.beem.2007.06.003","article-title":"Consequences of the ESPE\/LWPES guidelines for diagnosis and treatment of disorders of sex development","volume":"21","author":"Hughes","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/andr.12309","article-title":"Sexuality and fertility in men with hypospadias; improved outcome","volume":"5","author":"\u00d6rtqvist","year":"2017","journal-title":"Andrology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/bdra.23021","article-title":"Environmental and genetic contributors to hypospadias: a review of the epidemiologic evidence","volume":"94","author":"Carmichael","year":"2012","journal-title":"Birth Defects Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.juro.2013.09.058","article-title":"Population based nationwide study of hypospadias in Sweden, 1973 to 2009: incidence and risk factors","volume":"191","author":"Nordenvall","year":"2014","journal-title":"J Urol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S1477513124005102","DOI":"10.1016\/j.jpurol.2024.09.025","article-title":"The role of genetics in the etiology of hypospadias","author":"Turkyilmaz","year":"2024","journal-title":"J Pediatr Urol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jpurol.2024.07.001","article-title":"The possible role of epigenetics in the etiology of hypospadias","volume":"20","author":"Y\u0131ld\u0131z","year":"2024","journal-title":"J Pediatr Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e24117","DOI":"10.1371\/journal.pone.0024117","article-title":"Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46, XY disorders of sex development (DSD) including hypospadias","volume":"6","author":"Allali","year":"2011","journal-title":"PLoS One"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1524953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:40:08Z","timestamp":1738305608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1524953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":16,"alternative-id":["10.3389\/fsurg.2025.1524953"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1524953","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"1524953"}}